MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1498.12

Change

+20.48 (+1.39)%

Market Cap

N/A

Volume

0.23M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.65 (-0.24%)

USD 198.03B
IQV IQVIA Holdings Inc

+0.39 (+0.17%)

USD 42.80B
A Agilent Technologies Inc

-0.02 (-0.01%)

USD 42.11B
LH Laboratory Corporation of Amer..

-0.20 (-0.09%)

USD 18.52B
DGX Quest Diagnostics Incorporated

+0.91 (+0.59%)

USD 17.19B
CRL Charles River Laboratories

-1.18 (-0.61%)

USD 10.65B
QGEN Qiagen NV

-0.56 (-1.25%)

USD 10.05B
ENZ Enzo Biochem Inc

+0.03 (+2.70%)

USD 0.06B
VNRX Volitionrx Ltd

+0.06 (+8.59%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

-0.22 (-0.04%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.01 (-0.89%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 3.05 % 0.47 %

+0.03 (+-0.89%)

USD 7.60B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.01 (+-0.89%)

N/A
BMED BlackRock Future Health E.. 2.35 % 0.00 %

-0.05 (-0.89%)

USD 4.21M
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

+0.02 (+-0.89%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.10 (-0.89%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 1.69 % 0.00 %

N/A

CAD 0.01B
HECO 0.00 % 0.95 %

N/A

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

-0.34 (-0.89%)

CAD 0.27B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.51% 100% F 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.51% 100% F 81% B-
Trailing 12 Months  
Capital Gain 37.20% 100% F 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.20% 100% F 78% C+
Trailing 5 Years  
Capital Gain 118.30% 100% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 118.30% 100% F 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 16.66% N/A N/A 80% B-
Dividend Return 16.66% N/A N/A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.83% N/A N/A 33% F
Risk Adjusted Return 54.03% N/A N/A 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike